{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:12:45Z","timestamp":1762254765794,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82070291"],"award-info":[{"award-number":["82070291"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Muscone is a chemical monomer derived from musk. Although many studies have confirmed the cardioprotective effects of muscone, the effects of muscone on cardiac hypertrophy and its potential mechanisms are unclear.The aim of the present study was to investigate the effect of muscone on angiotensin (Ang) II-induced cardiac hypertrophy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods and results<\/jats:title>\n            <jats:p>In the present study, we found for the first time that muscone exerted inhibitory effects on Ang II-induced cardiac hypertrophy and cardiac injury in mice. Cardiac function was analyzed by echocardiography measurement, and the degree of cardiac fibrosis was determined by the quantitative real-time polymerase chain reaction (qRT-PCR), Masson trichrome staining and western blot assay. Secondly, qRT-PCR experiment showed that muscone attenuated cardiac injury by reducing the secretion of pro-inflammatory cytokines and promoting the secretion of anti-inflammatory cytokines. Moreover, western blot analysis found that muscone exerted cardio-protective effects by inhibiting phosphorylation of key proteins in the STAT3, MAPK and TGF-\u03b2\/SMAD pathways. In addition, CCK-8 and determination of serum biochemical indexes showed that no significant toxicity or side effects of muscone on normal cells and organs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Muscone could attenuate Ang II-induced cardiac hypertrophy, in part, by inhibiting the STAT3, MAPK, and TGF-\u03b2\/SMAD signaling pathways.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11033-023-08916-1","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T17:01:57Z","timestamp":1703869317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Muscone inhibits angiotensin II\u2013induced cardiac hypertrophy through the STAT3, MAPK and TGF-\u03b2\/SMAD signaling pathways"],"prefix":"10.1007","volume":"51","author":[{"given":"Yi-jiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-jia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong-gui","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"key":"8916_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","volume":"97","author":"I Shimizu","year":"2016","unstructured":"Shimizu I, Minamino T (2016) Physiological and pathological cardiac hypertrophy. J Mol Cell Cardiol 97:245\u2013262. https:\/\/doi.org\/10.1016\/j.yjmcc.2016.06.001","journal-title":"J Mol Cell Cardiol"},{"key":"8916_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.pharmthera.2012.06.006","volume":"135","author":"J Hou","year":"2012","unstructured":"Hou J, Kang YJ (2012) Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets. Pharmacol Ther 135:337\u2013354. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.06.006","journal-title":"Pharmacol Ther"},{"key":"8916_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J (2018) Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol 15:387\u2013407. https:\/\/doi.org\/10.1038\/s41569-018-0007-y","journal-title":"Nat Rev Cardiol"},{"key":"8916_CR4","doi-asserted-by":"publisher","first-page":"153461","DOI":"10.1016\/j.phymed.2021.153461","volume":"82","author":"J Gu","year":"2021","unstructured":"Gu J, Qiu M, Lu Y, Ji Y, Qian Z, Sun W (2021) Piperlongumine attenuates angiotensin-II-induced cardiac hypertrophy and fibrosis by inhibiting Akt-FoxO1 signalling. Phytomedicine 82:153461. https:\/\/doi.org\/10.1016\/j.phymed.2021.153461","journal-title":"Phytomedicine"},{"key":"8916_CR5","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1161\/circulationaha.114.008788","volume":"131","author":"RA Frieler","year":"2015","unstructured":"Frieler RA, Mortensen RM (2015) Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling. Circulation 131:1019\u20131030. https:\/\/doi.org\/10.1161\/circulationaha.114.008788","journal-title":"Circulation"},{"key":"8916_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bph.13344","volume":"173","author":"J Heger","year":"2016","unstructured":"Heger J, Schulz R, Euler G (2016) Molecular switches under TGF\u03b2 signalling during progression from cardiac hypertrophy to Heart Failure. Br J Pharmacol 173:3\u201314. https:\/\/doi.org\/10.1111\/bph.13344","journal-title":"Br J Pharmacol"},{"key":"8916_CR7","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.cmet.2015.11.013","volume":"23","author":"J Zhang","year":"2016","unstructured":"Zhang J, Rudemiller NP, Patel MB, Karlovich NS, Wu M, McDonough AA, Griffiths R, Sparks MA, Jeffs AD, Crowley SD (2016) Interleukin-1 receptor activation potentiates Salt Reabsorption in Angiotensin II-Induced Hypertension via the NKCC2 co-transporter in the Nephron. Cell Metab 23:360\u2013368. https:\/\/doi.org\/10.1016\/j.cmet.2015.11.013","journal-title":"Cell Metab"},{"key":"8916_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41577-019-0160-5","volume":"19","author":"GR Drummond","year":"2019","unstructured":"Drummond GR, Vinh A, Guzik TJ, Sobey CG (2019) Immune mechanisms of Hypertension. Nat Rev Immunol 19:517\u2013532. https:\/\/doi.org\/10.1038\/s41577-019-0160-5","journal-title":"Nat Rev Immunol"},{"key":"8916_CR9","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.humimm.2016.07.232","volume":"77","author":"N Inoue","year":"2016","unstructured":"Inoue N, Watanabe M, Ishido N, Kodu A, Maruoka H, Katsumata Y, Hidaka Y, Iwatani Y (2016) Involvement of genes encoding apoptosis regulatory factors (FAS, FASL, TRAIL, BCL2, TNFR1 and TNFR2) in the pathogenesis of autoimmune thyroid Diseases. Hum Immunol 77:944\u2013951. https:\/\/doi.org\/10.1016\/j.humimm.2016.07.232","journal-title":"Hum Immunol"},{"key":"8916_CR10","doi-asserted-by":"publisher","unstructured":"Delaitre C, Boisbrun M, Lecat S, Dupuis F (2021) Targeting the angiotensin II type 1 receptor in Cerebrovascular Diseases: Biased Signaling raises new hopes. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms22136738","DOI":"10.3390\/ijms22136738"},{"key":"8916_CR11","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1161\/hypertensionaha.118.10266","volume":"71","author":"S Eguchi","year":"2018","unstructured":"Eguchi S, Kawai T, Scalia R, Rizzo V (2018) Understanding angiotensin II type 1 receptor signaling in vascular pathophysiology. Hypertension 71:804\u2013810. https:\/\/doi.org\/10.1161\/hypertensionaha.118.10266","journal-title":"Hypertension"},{"key":"8916_CR12","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","volume":"51","author":"M Dobaczewski","year":"2011","unstructured":"Dobaczewski M, Chen W, Frangogiannis NG (2011) Transforming growth factor (TGF)-\u03b2 signaling in cardiac remodeling. J Mol Cell Cardiol 51:600\u2013606. https:\/\/doi.org\/10.1016\/j.yjmcc.2010.10.033","journal-title":"J Mol Cell Cardiol"},{"key":"8916_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12967-019-1857-8","volume":"17","author":"Z Geng","year":"2019","unstructured":"Geng Z, Fan WY, Zhou B, Ye C, Tong Y, Zhou YB, Xiong XQ (2019) FNDC5 attenuates obesity-induced cardiac hypertrophy by inactivating JAK2\/STAT3-associated inflammation and oxidative stress. J Transl Med 17:107. https:\/\/doi.org\/10.1186\/s12967-019-1857-8","journal-title":"J Transl Med"},{"key":"8916_CR14","doi-asserted-by":"publisher","first-page":"18975","DOI":"10.1038\/srep18975","volume":"6","author":"D Li","year":"2016","unstructured":"Li D, Chen B, Zhang L, Gaur U, Ma T, Jie H, Zhao G, Wu N, Xu Z, Xu H, Yao Y, Lian T, Fan X, Yang D, Yang M, Zhu Q, Satkoski Trask J (2016) The musk chemical composition and microbiota of Chinese forest musk deer males. Sci Rep 6:18975. https:\/\/doi.org\/10.1038\/srep18975","journal-title":"Sci Rep"},{"key":"8916_CR15","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/0006-2952(86)90287-x","volume":"35","author":"R Peng","year":"1986","unstructured":"Peng R, Zhu XY, Yang CS (1986) Induction of rat liver microsomal cytochrome P-450 by muscone (3-methylcyclopentadecanone). Biochem Pharmacol 35:1391\u20131394. https:\/\/doi.org\/10.1016\/0006-2952(86)90287-x","journal-title":"Biochem Pharmacol"},{"key":"8916_CR16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/0006-2952(91)90551-f","volume":"41","author":"E Tanaka","year":"1991","unstructured":"Tanaka E, Funae Y, Imaoka S, Misawa S (1991) Characterization of liver microsomal cytochrome P450 from rats treated with muscone (3-methylcyclopentadecanone). Biochem Pharmacol 41:472\u2013473. https:\/\/doi.org\/10.1016\/0006-2952(91)90551-f","journal-title":"Biochem Pharmacol"},{"key":"8916_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3892\/ijmm.2014.1766","volume":"34","author":"X Wang","year":"2014","unstructured":"Wang X, Meng H, Chen P, Yang N, Lu X, Wang ZM, Gao W, Zhou N, Zhang M, Xu Z, Chen B, Tao Z, Wang L, Yang Z, Zhu T (2014) Beneficial effects of muscone on cardiac remodeling in a mouse model of Myocardial Infarction. Int J Mol Med 34:103\u2013111. https:\/\/doi.org\/10.3892\/ijmm.2014.1766","journal-title":"Int J Mol Med"},{"key":"8916_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jep.2011.08.009","volume":"138","author":"Q Wu","year":"2011","unstructured":"Wu Q, Li H, Wu Y, Shen W, Zeng L, Cheng H, He L (2011) Protective effects of muscone on ischemia-reperfusion injury in cardiac myocytes. J Ethnopharmacol 138:34\u201339. https:\/\/doi.org\/10.1016\/j.jep.2011.08.009","journal-title":"J Ethnopharmacol"},{"key":"8916_CR19","doi-asserted-by":"publisher","first-page":"8870","DOI":"10.12659\/msm.912051","volume":"24","author":"Y Du","year":"2018","unstructured":"Du Y, Ge Y, Xu Z, Aa N, Gu X, Meng H, Lin Z, Zhu D, Shi J, Zhuang R, Wu X, Wang X, Yang Z (2018) Hypoxia-inducible factor 1 alpha (HIF-1\u03b1)\/Vascular endothelial growth factor (VEGF) pathway participates in angiogenesis of Myocardial Infarction in muscone-treated mice: preliminary study. Med Sci Monit 24:8870\u20138877. https:\/\/doi.org\/10.12659\/msm.912051","journal-title":"Med Sci Monit"},{"key":"8916_CR20","doi-asserted-by":"publisher","first-page":"166539","DOI":"10.1016\/j.bbadis.2022.166539","volume":"1868","author":"LL Zhu","year":"2022","unstructured":"Zhu LL, Cao GY, Jia LY, Zheng G, Zhang L, Sheng P, Meng ZQ, He X, Zhang CF, Wang CZ, Yuan CS (2022) Muscone suppresses myocardial ischemia damage by regulating PI3K\/Akt signaling pathway. Biochim Biophys Acta Mol Basis Dis 1868:166539. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166539","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"8916_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1139\/cjpp-2019-0566","volume":"98","author":"CJ Oldfield","year":"2020","unstructured":"Oldfield CJ, Duhamel TA, Dhalla NS (2020) Mechanisms for the transition from physiological to pathological cardiac hypertrophy. Can J Physiol Pharmacol 98:74\u201384. https:\/\/doi.org\/10.1139\/cjpp-2019-0566","journal-title":"Can J Physiol Pharmacol"},{"key":"8916_CR22","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/hypertensionaha.118.12267","volume":"73","author":"S Kumar","year":"2019","unstructured":"Kumar S, Wang G, Zheng N, Cheng W, Ouyang K, Lin H, Liao Y, Liu J (2019) HIMF (Hypoxia-Induced Mitogenic Factor)-IL (Interleukin)-6 signaling mediates cardiomyocyte-fibroblast crosstalk to promote Cardiac Hypertrophy and Fibrosis. Hypertension 73:1058\u20131070. https:\/\/doi.org\/10.1161\/hypertensionaha.118.12267","journal-title":"Hypertension"},{"key":"8916_CR23","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1016\/j.bbadis.2018.07.035","volume":"1864","author":"J Jiang","year":"2018","unstructured":"Jiang J, Lan C, Li L, Yang D, Xia X, Liao Q, Fu W, Chen X, An S, Wang WE, Zeng C (2018) A novel porcupine inhibitor blocks WNT pathways and attenuates cardiac hypertrophy. Biochim Biophys Acta Mol Basis Dis 1864:3459\u20133467. https:\/\/doi.org\/10.1016\/j.bbadis.2018.07.035","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"Suppl 1","key":"8916_CR24","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1097\/01.hjh.0000388488.51083.2b","volume":"28","author":"RJ Reiter","year":"2010","unstructured":"Reiter RJ, Manchester LC, Fuentes-Broto L, Tan DX (2010) Cardiac hypertrophy and remodelling: pathophysiological consequences and protective effects of melatonin. J Hypertens 28(Suppl 1):S7\u201312. https:\/\/doi.org\/10.1097\/01.hjh.0000388488.51083.2b","journal-title":"J Hypertens"},{"key":"8916_CR25","doi-asserted-by":"publisher","first-page":"111022","DOI":"10.1016\/j.biopha.2020.111022","volume":"133","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Shen A, Wu X, Shen Z, Chen X, Li J, Liu L, Lin X, Wu M, Chen Y, Chu J, Peng J (2021) Qingda granule attenuates angiotensin II-induced cardiac hypertrophy and apoptosis and modulates the PI3K\/AKT pathway. Biomed Pharmacother 133:111022. https:\/\/doi.org\/10.1016\/j.biopha.2020.111022","journal-title":"Biomed Pharmacother"},{"key":"8916_CR26","doi-asserted-by":"publisher","first-page":"3764370","DOI":"10.1155\/2017\/3764370","volume":"2017","author":"B Wu","year":"2017","unstructured":"Wu B, Lin J, Luo J, Han D, Fan M, Guo T, Tao L, Yuan M, Yi F (2017) Dihydromyricetin protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic mice. Biomed Res Int 2017:3764370. https:\/\/doi.org\/10.1155\/2017\/3764370","journal-title":"Biomed Res Int"},{"key":"8916_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41401-019-0307-8","volume":"41","author":"Y Bian","year":"2020","unstructured":"Bian Y, Li X, Pang P, Hu XL, Yu ST, Liu YN, Li X, Wang N, Wang JH, Xiao W, Du WJ, Yang BF (2020) Kanglexin, a novel anthraquinone compound, protects against myocardial ischemic injury in mice by suppressing NLRP3 and pyroptosis. Acta Pharmacol Sin 41:319\u2013326. https:\/\/doi.org\/10.1038\/s41401-019-0307-8","journal-title":"Acta Pharmacol Sin"},{"key":"8916_CR28","doi-asserted-by":"publisher","first-page":"113120","DOI":"10.1016\/j.jep.2020.113120","volume":"262","author":"J Wang","year":"2020","unstructured":"Wang J, Xing H, Qin X, Ren Q, Yang J, Li L (2020) Pharmacological effects and mechanisms of muscone. J Ethnopharmacol 262:113120. https:\/\/doi.org\/10.1016\/j.jep.2020.113120","journal-title":"J Ethnopharmacol"},{"key":"8916_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.23812\/20-101-a","volume":"35","author":"CJ Wei","year":"2021","unstructured":"Wei CJ, Hua F, Chen YH, Zhang ZW, Shen ZY (2021) Muscone alleviates myocardial ischemia-reperfusion injury via inhibition of oxidative stress and enhancement of SIRT3. J Biol Regul Homeost Agents 35:85\u201396. https:\/\/doi.org\/10.23812\/20-101-a","journal-title":"J Biol Regul Homeost Agents"},{"key":"8916_CR30","doi-asserted-by":"publisher","first-page":"9112479","DOI":"10.1155\/2022\/9112479","volume":"2022","author":"H Zhang","year":"2022","unstructured":"Zhang H, Ye J, Wang X, Liu Z, Chen T, Gao J (2022) Muscone inhibits the excessive inflammatory response in Myocardial Infarction by targeting TREM-1. Evid Based Complement Alternat Med 2022:9112479. https:\/\/doi.org\/10.1155\/2022\/9112479","journal-title":"Evid Based Complement Alternat Med"},{"key":"8916_CR31","first-page":"4235","volume":"10","author":"Y Du","year":"2018","unstructured":"Du Y, Gu X, Meng H, Aa N, Liu S, Peng C, Ge Y, Yang Z (2018) Muscone improves cardiac function in mice after Myocardial Infarction by alleviating cardiac macrophage-mediated chronic inflammation through inhibition of NF-\u03baB and NLRP3 inflammasome. Am J Transl Res 10:4235\u20134246","journal-title":"Am J Transl Res"},{"key":"8916_CR32","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/ehf2.13177","volume":"8","author":"ES Nord\u00e9n","year":"2021","unstructured":"Nord\u00e9n ES, Bendiksen BA, Andresen H, Bergo KK, Espe EK, Hasic A, Hauge-Iversen IM, Veras I, Hussain RI, Sjaastad I, Christensen G, Cataliotti A (2021) Sacubitril\/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload. ESC Heart Fail 8:918\u2013927. https:\/\/doi.org\/10.1002\/ehf2.13177","journal-title":"ESC Heart Fail"},{"key":"8916_CR33","doi-asserted-by":"publisher","first-page":"e005565","DOI":"10.1161\/circheartfailure.118.005565","volume":"12","author":"RM Burke","year":"2019","unstructured":"Burke RM, Lighthouse JK, Mickelsen DM, Small EM (2019) Sacubitril\/Valsartan decreases Cardiac Fibrosis in Left ventricle pressure overload by restoring PKG Signaling in Cardiac fibroblasts. Circ Heart Fail 12:e005565. https:\/\/doi.org\/10.1161\/circheartfailure.118.005565","journal-title":"Circ Heart Fail"},{"key":"8916_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000314270","volume":"2","author":"MG Ionita","year":"2010","unstructured":"Ionita MG, Arslan F, de Kleijn DP, Pasterkamp G (2010) Endogenous inflammatory molecules engage toll-like receptors in Cardiovascular Disease. J Innate Immun 2:307\u2013315. https:\/\/doi.org\/10.1159\/000314270","journal-title":"J Innate Immun"},{"key":"8916_CR35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1161\/hypertensionaha.109.148635","volume":"56","author":"GC Mel\u00e9ndez","year":"2010","unstructured":"Mel\u00e9ndez GC, McLarty JL, Levick SP, Du Y, Janicki JS, Brower GL (2010) Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension 56:225\u2013231. https:\/\/doi.org\/10.1161\/hypertensionaha.109.148635","journal-title":"Hypertension"},{"key":"8916_CR36","doi-asserted-by":"publisher","first-page":"6304058","DOI":"10.1155\/2019\/6304058","volume":"2019","author":"HH Liao","year":"2019","unstructured":"Liao HH, Zhang N, Meng YY, Feng H, Yang JJ, Li WJ, Chen S, Wu HM, Deng W, Tang QZ (2019) Myricetin alleviates pathological Cardiac Hypertrophy via TRAF6\/TAK1\/MAPK and Nrf2 signaling pathway. Oxid Med Cell Longev 2019:6304058. https:\/\/doi.org\/10.1155\/2019\/6304058","journal-title":"Oxid Med Cell Longev"},{"key":"8916_CR37","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.bbadis.2019.01.020","volume":"1865","author":"D Chen","year":"2019","unstructured":"Chen D, Li Z, Bao P, Chen M, Zhang M, Yan F, Xu Y, Ji C, Hu X, Sanchis D, Zhang Y, Ye J (2019) Nrf2 deficiency aggravates angiotensin II-induced cardiac injury by increasing hypertrophy and enhancing IL-6\/STAT3-dependent inflammation. Biochim Biophys Acta Mol Basis Dis 1865:1253\u20131264. https:\/\/doi.org\/10.1016\/j.bbadis.2019.01.020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"8916_CR38","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/jcb.22623","volume":"110","author":"W Ai","year":"2010","unstructured":"Ai W, Zhang Y, Tang QZ, Yan L, Bian ZY, Liu C, Huang H, Bai X, Yin L, Li H (2010) Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling. J Cell Biochem 110:1111\u20131122. https:\/\/doi.org\/10.1002\/jcb.22623","journal-title":"J Cell Biochem"},{"key":"8916_CR39","doi-asserted-by":"publisher","unstructured":"Zeng SY, Yan QJ, Yang L, Mei QH, Lu HQ (2020) Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1\/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1\/2. Mediators Inflamm 2020:1078365. https:\/\/doi.org\/10.1155\/2020\/1078365","DOI":"10.1155\/2020\/1078365"},{"key":"8916_CR40","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","volume":"89","author":"YK Tham","year":"2015","unstructured":"Tham YK, Bernardo BC, Ooi JY, Weeks KL, McMullen JR (2015) Pathophysiology of cardiac hypertrophy and Heart Failure: signaling pathways and novel therapeutic targets. Arch Toxicol 89:1401\u20131438. https:\/\/doi.org\/10.1007\/s00204-015-1477-x","journal-title":"Arch Toxicol"},{"key":"8916_CR41","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.cellsig.2012.12.008","volume":"25","author":"A Fahmi","year":"2013","unstructured":"Fahmi A, Smart N, Punn A, Jabr R, Marber M, Heads R (2013) p42\/p44-MAPK and PI3K are sufficient for IL-6 family cytokines\/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK\/STAT activation. Cell Signal 25:898\u2013909. https:\/\/doi.org\/10.1016\/j.cellsig.2012.12.008","journal-title":"Cell Signal"},{"key":"8916_CR42","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1111\/jphp.13157","volume":"71","author":"J Dong","year":"2019","unstructured":"Dong J, Li H, Bai Y, Wu C (2019) Muscone ameliorates diabetic peripheral neuropathy through activating AKT\/mTOR signalling pathway. J Pharm Pharmacol 71:1706\u20131713. https:\/\/doi.org\/10.1111\/jphp.13157","journal-title":"J Pharm Pharmacol"},{"key":"8916_CR43","doi-asserted-by":"publisher","first-page":"106355","DOI":"10.1016\/j.intimp.2020.106355","volume":"82","author":"S Yu","year":"2020","unstructured":"Yu S, Zhao G, Han F, Liang W, Jiao Y, Li Z, Li L (2020) Muscone relieves inflammatory pain by inhibiting microglial activation-mediated inflammatory response via abrogation of the NOX4\/JAK2-STAT3 pathway and NLRP3 inflammasome. Int Immunopharmacol 82:106355. https:\/\/doi.org\/10.1016\/j.intimp.2020.106355","journal-title":"Int Immunopharmacol"},{"key":"8916_CR44","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1007\/s11999-009-1079-0","volume":"468","author":"QQ Liang","year":"2010","unstructured":"Liang QQ, Zhang M, Zhou Q, Shi Q, Wang YJ (2010) Muscone protects vertebral end-plate degeneration by antiinflammatory property. Clin Orthop Relat Res 468:1600\u20131610. https:\/\/doi.org\/10.1007\/s11999-009-1079-0","journal-title":"Clin Orthop Relat Res"},{"key":"8916_CR45","doi-asserted-by":"publisher","first-page":"3322535","DOI":"10.1155\/2022\/3322535","volume":"2022","author":"H Liu","year":"2022","unstructured":"Liu H, Liu LL, Chen J, Chen YW, Chai Y, Liu QS, Cheng Y (2022) Muscone with attenuation of Neuroinflammation and oxidative stress exerts antidepressant-like Effect in Mouse Model of Chronic Restraint stress. Oxid Med Cell Longev 2022:3322535. https:\/\/doi.org\/10.1155\/2022\/3322535","journal-title":"Oxid Med Cell Longev"},{"key":"8916_CR46","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1142\/s0192415x20500287","volume":"48","author":"MC He","year":"2020","unstructured":"He MC, Shi Z, Qin M, Sha NN, Li Y, Liao DF, Lin FH, Shu B, Sun YL, Yuan TF, Wang YJ, Zhang Y (2020) Muscone ameliorates LPS-Induced Depressive-Like behaviors and inhibits neuroinflammation in Prefrontal Cortex of mice. Am J Chin Med 48:559\u2013577. https:\/\/doi.org\/10.1142\/s0192415x20500287","journal-title":"Am J Chin Med"},{"key":"8916_CR47","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/jnc.15011","volume":"155","author":"LY Zhou","year":"2020","unstructured":"Zhou LY, Yao M, Tian ZR, Liu SF, Song YJ, Ye J, Li G, Sun YL, Cui XJ, Wang YJ (2020) Muscone suppresses inflammatory responses and neuronal damage in a rat model of cervical spondylotic myelopathy by regulating Drp1-dependent mitochondrial fission. J Neurochem 155:154\u2013176. https:\/\/doi.org\/10.1111\/jnc.15011","journal-title":"J Neurochem"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08916-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-08916-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08916-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T20:34:34Z","timestamp":1738701274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-08916-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,29]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["8916"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-08916-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2023,12,29]]},"assertion":[{"value":"20 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental procedures followed the guidelines of the Care and Use of Laboratory Animals issued by the Chinese Council on Animal Research. The use of laboratory animals was approved by the Animal Ethics Committee of Xiamen University (Approval No. XMULAC20220094).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}